Overview
RTK Group is a family office backed biopharmaceutical advisory and investment fund focused on emerging technologies having disruptive impact and significant potential to benefit patients. We focus our efforts where we can leverage our unique expertise in company formation and technology development to assist high‐performing management teams realize the full value potential of their technology.